Payer & Market Access Expert - Gross-to-Net & Formulary Strategy

This role is for one of our clients

Compensation: $175-$200 per hour

A leading biotech and pharmaceutical research organization is conducting a paid expert-evaluation initiative focused on improving how AI systems analyze commercial drugs and drug-development programs.

We are seeking an experienced Payer & Market Access Expert with strong knowledge of pricing, reimbursement, gross-to-net dynamics, rebates, and formulary strategy. You will help create and evaluate structured rubrics designed to assess whether AI-generated analyses accurately reflect real-world payer and market access practices.

This is a paid pilot engagement with the potential for continued work as the program expands.

• Create, review, and critique evaluation rubrics for analyzing commercial drugs and pharmaceutical development programs.
• Establish and pressure-test gross-to-net assumptions, including rebates, discounts, and other pricing considerations across relevant drug classes.
• Evaluate whether assumptions regarding formulary placement, coverage, utilization management, and payer behavior accurately reflect real-world market access practices.
• Assess payer and reimbursement considerations across different therapeutic areas and drug classes.
• Apply market access expertise consistently across the pilot's assigned portfolio of drugs and development programs.
• Identify unrealistic, incomplete, or unsupported assumptions and provide clear recommendations for improving evaluation criteria.
• Help ensure rubrics are practical, rigorous, and aligned with how experienced payer and market access professionals evaluate commercial opportunities.

• 5+ years of professional experience in market access, pricing and reimbursement, managed markets, payer strategy, or a closely related field.
• Currently based in the United States.
• Hands-on understanding of gross-to-net modeling, rebates, discounts, formulary tiering, and payer coverage dynamics.
• Familiarity with biotech and pharmaceutical drug-development programs and commercialization processes.
• Strong understanding of how payer behavior varies across drug classes, therapeutic categories, and commercial situations.
• Ability to critically evaluate assumptions and determine whether they are commercially realistic and supported by industry practice.
• Strong analytical reasoning and attention to detail.
• Excellent written communication skills, with the ability to clearly explain the rationale behind professional judgments.
• Comfortable working independently and providing structured feedback within defined evaluation frameworks.

• Duration: Approximately 10–20 hours over a 1–2 week pilot.
• Location: Fully remote, United States.
• Engagement Type: Paid expert evaluation pilot.
• Potential Extension: Strong contributors may have opportunities for recurring engagements as the program expands.